Vol. 2 No. 2 (2022): Precision Medicine Communications

View Vol. 2 No. 2 (2022): Precision Medicine Communications

Published: 2022-12-31

Editorial

Precision Medicine and Cancer Chemotherapy

Sami Siraj

79
- PDF

In This Issue

Editor's Summaries of the Articles Published in This Issue of Precision Medicine Communications

Editorial Staff

81-83
- PDF

Editor's Choice

Predicting Stroke risk in a Chinese Han Population From Liaoning, China

Editorial Staff

85-89
Resistance of Breast Cancer Cells to Paclitaxel Elucidated

Editorial Staff

85-89
Plasma Simvastatin Variations with CYP3A4*22 and CYP3A5*3

Editorial Staff

85-89
Anti-TNF-α Treatment Response in Ankylosing Spondylitis Depends on Gut Microbiota

Editorial Staff

85-89
Prediction of Toxicities Induced by Sorafenib and Regorafenib

Editorial Staff

85-89

Research Articles

Evidence-Based Prioritization and Scoring of Genomic Loci Interacting with Pioglitazone Therapeutic Response in Diabetic Patients.

Anum, Muhammad Imran Amirzada, Zia Uddin, Muhammad Ikram, Abdul Jabbar Shah, Nabi Shah

91-108
- PDF
Cytochrome P450 2C19*2 Genetic Polymorphism in Patients with Acute Coronary Syndrome

Fawad Hasan, Zahid Khan, Mahmood ul Hassan

109-117

Review Articles

Escitalopram Use in Depression & the Influence of Genetic Variations on Its Safety & Efficacy

Tahreem Zaheer, Fatima Shahid, Pratima Chhetri

119-132
- PDF
Single Nucleotide Polymorphisms Associated with the Safety and Efficacy of Anti-Gout Medications

Manzoor Ahmed, Vahid Nikoui, Hiba Imran

133-154
The Genetic Influence on the Antihypertensive and Uricosuric Actions of Losartan

Eman Aamir, Hareem Arif Siddiqui, Aemen Haroon

155-167
- PDF